Want tender expert help? See our tender preparation service
Tenders

Procurement of substitute medicines for the National Institute for Health Development

Open
In brief

Riigi Tugiteenuste Keskus is procuring addiction treatment supplies, specifically methadone hydrochloride and buprenorphine/naloxone combination medicine, for the Health Development Institute in Estonia. The estimated value is 380,000 EUR. The deadline for submission is 11 December 2026. This tender is divided into lots. Notice, tender documents and submission instructions are available on the riigihanked.riik.ee portal.

Updated November 13, 2026

Deadline
25 days left
December 11, 2026
Contract Details
Category
Supplies
Reference
314616
Value
€380,000
Location
Estonia
Published
November 11, 2026
CPV Code
Project Timeline

Tender Published

November 11, 2026

Deadline for Questions

December 04, 2026

Submission Deadline

December 11, 2026

Tender Opening

December 11, 2026

Win ProbabilityPRO
🔒
Upgrade to Professional
See your estimated win probability based on historical data.
Upgrade to Professional →
Buyer IntelligencePRO
🔒
Unlock Buyer Intelligence
See spending patterns, preferred procedures, and more.
Upgrade to Professional →
Sector InsightsPRO
🔒
Unlock Sector Insights
See average winning prices, competition levels, and market trends.
Upgrade to Professional →

Key facts

Estimated value
€380,000
Deadline
25 days left
CPV Code
33693300-7 — Addiction treatment
Procedure
Open procedure
Lots
Divided into lots
Budget
€380,000
Duration
Not specified
Location
Estonia
Type
Supplies
Market Benchmark
Avg. Winning Price
€92,792
Avg. Bids
2.2
Competition
Low
SME Winners
86%
3,220 tenders analyzed

Original Tender Description

Asendusravimite hankimine Tervise Arengu Instituudile: OSA I: metadoonvesinikkloriid 1 mg/ml, suukaudne (peroraalne) lahus; Pakendi maht 1 000 ml või funktsionaalselt samaväärne kogus (nt 2 × 500 ml). Eeldatav kogus (mitte siduv) on kokku 12 000 liitrit metadoonvesinikkloriidi 1 mg/ml suukaudset lahust. Tellija esitab tellimusi vastavalt reaalsele vajadusele. OSA II: Kombinatsioonravim buprenorfiin/naloksoon; Buprenorfiini ja naloksooni kombinatsioonravim, mis sisaldab ühes tabletis 8 mg buprenorfiini ja 2 mg naloksooni. Tablett peab olema poolitusjoonega ning jagatav võrdseteks annusteks. Eeldatav kogus (mitte siduv) on 7 000 tabletti, millest igaüks vastab 8 mg buprenorfiini ja 2 mg naloksooni sisaldavale annusele. Tellija esitab tellimusi vastavalt reaalsele vajadusele.
Electronic Submission

Run Risk Analysis

Identify potential risks, inconsistencies, and red flags across all tender documents. Get a detailed risk report with severity levels and mitigation recommendations.

Login

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Login

Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

6 documents available with AI summaries

VastavustingimusedPDF
314616_vastavustingimused.pdf -- 13.8 KB

No summary available for this document.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
314616_hindamiskriteeriumid.pdf -- 4.8 KB

No summary available for this document.

Hankepass täiendatavate selgitustegaPDF
314616_hankepass_taiendavate_selgitustega.pdf -- 43.2 KB

No summary available for this document.

LisateaveDOC
Lisateave.docx -- 39.8 KB

No summary available for this document.

Müügilepingu projektDOC
Müügileping.docx -- 51.3 KB

No summary available for this document.

Tehniline kirjeldusDOC
Tehniline_kirjeldus.docx -- 33.8 KB

No summary available for this document.

Documents Preview

Sign up to view document summaries and analysis

Quality Score

Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.

Login